Calgenex launches OTC psoriasis cream

1 October 2006

USA-based Calgenex Corp has introduced Dermalleve, its new over-the-counter topical drug treatment for psoriasis, eczema and seborrheic dermatitis. The product combines maximum-strength anti-pruritic medicine with natural skin conditioners and emollients to stop the itching, reduce inflammation and support the body's healing process.

Dermalleve contains 1% hydrocortisone, the maximum strength OTC anti-pruritic allowed by the US Food and Drug Administration. According to Calgenex, what sets its product apart from other topical treatments is its patent-pending blend of natural ingredients, including alpha-hydroxy acids, skin-nourishing nutrients and skin conditioners such as aloe vera, shea butter, vitamin E, jojoba oil and silicone. This novel lotion base helps to "gently remove dead skin cells while skin-nourishing nutrients, conditioners and moisturizers support healthy skin. In fact, whereas other anti-itch creams use inexpensive petroleum as a base, Dermalleve is made with 75% cooling and moisturizing purified aloe vera juice," the firm noted.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight